Transaction DateRecipientSharesTypePriceValue
29th June 2020Nora B Sullivan22,000Open or private purchase$0.78$17,160.00
22nd June 2020James A Mish150,000Grant/award etc.$0.00
8th June 2020John Franzino50,000Grant/award etc.$0.00
5th June 2020Nora B Sullivan29,953Open or private purchase$0.82$24,561.46
4th June 2020Nora B Sullivan71,372Open or private purchase$0.82$58,660.65
16th March 2020Richard M. Sanders126,823Grant/award etc.$0.00
16th March 2020Nora B Sullivan126,823Grant/award etc.$0.00
16th March 2020Roger D O'Brien126,823Grant/award etc.$0.00
16th March 2020Michael Zercher665,821Grant/award etc.$0.00
16th March 2020Clifford B Fleet126,823Grant/award etc.$0.00
22Nd Century Group
22Nd Century Group logo

22nd Century Group, Inc. is a plant biotechnology company. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes.

Ticker: XXII
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1347858
Employees: 67
Exchange: NYSE American
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Inventory, Net: $3 M (0%)
Assets, Current: $36 M (-15%)
Property, Plant and Equipment, Net: $4 M (-5%)
Assets: $61 M (-11%)
Accounts Payable, Current: $1 M (-48%)
Accrued Liabilities, Current: $2 M (-14%)
Liabilities, Current: $6 M (9%)
Common Stock, Value, Issued: $1 Th (0%)
Common Stock, Shares, Issued: $139 M (0%)
Retained Earnings (Accumulated Deficit): $135 M (7%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $52 Th (642%)
Stockholders' Equity (Parent): $54 M (0%)
Liabilities and Equity: $61 M (-11%)
Revenue: $6 M (0%)
Operating Income/Loss: $5 M (-46%)
Other Income, net: $304 Th (100%)